Lack of oral embryotoxicity/teratogenicity with d-ribose in Wistar rats

Food and Chemical Toxicology

Volumn 45, Issue 3, 2007, Pages 388-395

  Griffiths, James C ^a   Borzelleca, Joseph F ^b   Cyr, John St ^c  

^a Burdock Group   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c Bioenergy Inc   (United States)

Author keywords

Embryotoxicity; Rat; Ribose; Teratogenicity; Toxicity

Indexed keywords

DEOXYRIBOSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; FEMALE; FERTILITY; FETUS DEVELOPMENT; FETUS WEIGHT; MALE; METABOLIC STRESS; NONHUMAN; PLACENTA WEIGHT; PREIMPLANTATION EMBRYO; RAT; TERATOGENICITY; WISTAR RAT;

ANIMALS; CECUM; CONSUMER PRODUCT SAFETY; DIETARY SUPPLEMENTS; FEMALE; FETUS; INTUBATION, GASTROINTESTINAL; LIVER; MALE; MATERNAL EXPOSURE; PREGNANCY; RATS; RATS, WISTAR; RIBOSE; TOXICITY TESTS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 33846561186     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2006.08.019     Document Type: Article

References (53)

1. Anderson D.M. Dorland's Illustrated Medical Dictionary. 29th ed. (2000), W.B. Saunders Company, Philadelphia p. 1576
2. Angello D.A., Wilson R.A., and Gee D. Effect of ribose on thallium-201 myocardial redistribution. J. Nucl. Med. 29 (1988) 1943-1950
3. Anonymous. In: Budavari S. (Ed). The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals. 11th ed. (1989), Merck & Co., Inc., Rahway, NJ 8205
4. Bar A., Lina B.A., De Groot D.M., De Bie B., and Appel M.J. Effect of d-tagatose on liver weight and glycogen content of rats. Regul. Toxicol. Pharmacol. 29 (1999) S11-S28
5. Borzelleca J.F. A proposed model for safety assessment of macronutrient substitutes. Regul. Toxicol. Pharmacol. 23 (1996) S15-S18
6. Chang-Chien M.C., Huang P.C., and Tung T.C. Effects of prolonged feeding of d-xylose on rats. Taiwan Yi Xue Hui Za Zhi 72 (1973) 467-471
7. Clark P.A., and Harland W.A. The effect of dose on d-xylose excretion. Am. J. Dig. Dis. 12 (1967) 183-188
8. Cochran W.G. Analysis of covariance: it's nature and uses. Biometrics 13 (1957) 261-278
9. Collares E.F., Rossi M.A., and Macedo A.d. Experimental dilatation of the cecum and colon in rats I. Induction by continuous administration of lactose after weaning. Arq. Gastroenterol. 22 (1985) 136-140 (in Portuguese)
10. Craig R.M., and Ehrenpreis E.D. d-Xylose testing. J. Clin. Gastroenterol. 29 (1999) 143-150
11. Demetrakopoulos G.E., and Amos H. Xylose and xylitol. Metabolism, physiology and nutritional value. World Rev. Nutr. Diet. 32 (1978) 96-122
12. Dunnett C.W. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50 (1955) 1096-1121
13. Dunnett C.W. New tables for multiple comparison with a control. Biometrics 20 (1964) 482-492
14. Dybing E., Doe J., Groten J., Kleiner J., O'Brien J., Renwick A.G., Schlatter J., Steinberg P., Tritscher A., Walker R., and Younes M. Hazard characterisation of chemicals in food and diet dose response, mechanisms and extrapolation issues. Food. Chem. Toxicol. 40 (2002) 237-282
15. El-Harith E.A., Dickerson J.W., and Walker R. Potato starch and caecal hypertrophy in the rat. Food. Cosmet. Toxicol. 14 (1976) 115-121
16. Emms S.G., Hawkins C.D., and Clark W.T. The rate of d-xylose absorption in normal cats. Aust. Vet. J. 60 (1983) 30-31
17. FAO, 1998. FAO Food and Nutrition Paper #66: Carbohydrates in human nutrition. Food and Agriculture Organization/United Nations, Rome. Report Number: 66.
18. FDA. Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives Used in Food ('Redbook') (1982), US Food and Drug Administration, Washington, DC
19. FDA. Final rule: food additives permitted for direct addition to food for human consumption; sucralose. Federal Register 63 (1998) 16417-16433
20. FDA. Redbook 2000: Toxicological Principles for the Safety Assessment of Food Ingredients (2004), US Food and Drug Administration, Washington, DC. http://www.cfsan.fda.gov/~redbook/red-toca.html
21. FDA, 2005a. Report 21: 75-day Premarket Notification for New Dietary Ingredients: alpha-d-Ribofuranose. US Food and Drug Administration/Center for Food Safety and Applied Nutrition. Available from: .
22. FDA, 2005b. Report 63: 75-day Premarket Notification for New Dietary Ingredients: d-Ribose. US Food and Drug Administration/Center for Food Safety and Applied Nutrition. Available from: .
23. Ginsburg J., Boucher B., and Beaconsfield P. Hormonal changes during ribose-induced hypoglycemia. Diabetes 19 (1970) 23-27
24. Goetz F.C., Greenberg B.Z., Maney J.W., Wittmers R., and Nicoloff D. Indirect mechanism of insulin release from dog pancreas during infusions of d-ribose. Am. J. Physiol. 227 (1974) 1158-1165
25. Goodman C., and Goetz F.C. Oral and intravenous d-ribose and plasma insulin in healthy humans: effects of route of administration and of epinephrine and propranolol. Metabolism 19 (1970) 1094-1103
26. Griffiths, J.C., Borzelleca, J.F., St. Cyr, J., 2006. Subchronic (13-week) oral toxicity study with d-ribose in Wistar rats. Food Chem. Toxicol., in press, doi:10.1016/j.fct.2006.08.012.
27. Halter J.B., Schwartz M.Z., and Goetz F.C. The effect of oral and intravenous d-ribose on plasma insulin levels in unanesthetized dogs. Proc. Soc. Exp. Biol. Med. 127 (1968) 1147-1151
28. Hiatt H.H. Glycogen formation via the pentose phosphate pathway in mice in vivo. J. Biol. Chem. 224 (1957) 851-859
29. Imazawa T., Nishikawa A., Furukawa F., Ikeda T., Nakamura H., Miyauchi M., and Hirose M. A 13-week subchronic toxicity study of d-xylose in F344 rats. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku (1999) 115-118 (in Japanese)
30. Kast A. "Wavy ribs". A reversible pathologic finding in rat fetuses. Exp. Toxicol. Pathol. 46 (1994) 203-210
31. Kavlock R.J., Chernoff N., Gray Le J.R., Gray J.A., and Whitehouse D. Teratogenic effects of benomyl in the Wistar rat and CD-1 mouse, with emphasis on the route of administration. Toxicol. Appl. Pharmacol. 62 (1982) 44-54
32. Kruger C.L., Whittaker M.H., Frankos V.H., and Schroeder R.E. Developmental toxicity study of d-tagatose in rats. Regul. Toxicol. Pharmacol. 29 (1999) S29-S35
33. Kruger C.L., Whittaker M.H., Frankos V.H., and Trimmer G.W. 90-day oral toxicity study of d-tagatose in rats. Regul. Toxicol. Pharmacol. 29 (1999) S1-S10
34. Manson J.M., and Kang Y.J. Test methods for assessing female reproductive and developmental toxicology. In: Hayes A.W. (Ed). Principles and Methods of Toxicology. 3rd ed. (1994), Raven Press, Ltd., New York 989-1037
35. Marcus R., and Coulston A.M. Water-soluble vitamins: the vitamin B complex and ascorbic acid. In: Gilman A.G., Rall T.W., Nies A.S., and Taylor P. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. (1990), Pergamon Press, New York 1530-1536
36. Munro I.C., McGirr L.G., Nestmann E.R., and Kille J.W. Alternative approaches to the safety assessment of macronutrient substitutes. Regul. Toxicol. Pharmacol. 23 (1996) S6-S14
37. Newberne P.M., Conner M.W., and Estes P. The influence of food additives and related materials on lower bowel structure and function. Toxicol. Pathol. 16 (1988) 184-197
38. Nijjar M.S., and Perry W.F. Effects of intravenous and oral infusion of monosaccharides on serum insulin levels in rabbits. Diabetes 19 (1970) 155-160
39. OECD, 1988. OECD principles of GLP (Directive 88/320/EEC). Organisation for Economic Cooperation and Development (OECD), Paris, France.
40. OECD. Test guideline 408. Repeated dose 90-day oral toxicity study in rodents. OECD Guidelines for the Testing of Chemicals. Organisation for Economic Cooperation and Development (1998), Organisation for Economic Cooperation & Development (OECD), Paris, France
41. Pauly D.F., and Pepine C.J. d-Ribose as a supplement for cardiac energy metabolism. J. Cardiovasc. Pharmacol. Ther. 5 (2000) 249-258
42. Pauly D.F., Johnson C., and St. Cyr J.A. The benefits of ribose in cardiovascular disease. Med. Hypotheses 60 (2003) 149-151
43. Perlmutter N.S., Wilson R.A., Angello D.A., Palac R.T., Lin J., and Brown B.G. Ribose facilitates thallium-201 redistribution in patients with coronary artery disease. J. Nucl. Med. 32 (1991) 193-200
44. Poulsom R. Morphological changes of organs after sucrose or fructose feeding. Prog. Biochem. Pharmacol. 21 (1986) 104-134
45. Sable H.Z. Biosynthesis of ribose and deoxyribose. Adv. Enzymol. Relat. Areas Mol. Biol. 28 (1966) 391-460
46. Segals S., and Foley J. The metabolism of d-ribose in man. J. Clin. Invest. 37 (1958) 719-735
47. Siegel S. Fisher's test, Mann-Whitney U-test and Kruskal-Wallis nonparaetric ANOVA. Nonparametric Statistics for the Behavioral Sciences. 1st ed. (1956), McGraw-Hill, New York, NY pp. 96-104, 116-127, 184-194
48. Southgate D.A. Digestion and metabolism of sugars. Am. J. Clin. Nutr. 62 (1995) 203S-210S
49. Steel R.G.D., and Torrie J.H. Principles and Procedures of Statistics with Special Reference to the Biological Sciences. 1st ed. (1960), McGraw-Hill, New York, NY 305-311
50. Steinberg T., Poucher R.L., Sarin R.K., Rees R.B., and Gwinup G. Oral administration of d-ribose in diabetes mellitus. Diabetes 19 (1970) 11-16
51. Stryer L. Carbohydrates. In: Stryer L. (Ed). Biochemistry. 3rd ed. (1988), W.H. Freeman and Company, New York 331-337
52. Zimmer H.G. Normalization of depressed heart function in rats by ribose. Science 220 (1983) 81-82
53. Zimmer H.G., Ibel H., Suchner U., and Schad H. Ribose intervention in the cardiac pentose phosphate pathway is not species-specific. Science 223 (1984) 712-714